Nomura Asset Management Co. Ltd. Grows Position in Mettler-Toledo International Inc. (NYSE:MTD)

Nomura Asset Management Co. Ltd. lifted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,489 shares of the medical instruments supplier’s stock after purchasing an additional 30 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Mettler-Toledo International were worth $10,388,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of MTD. Townsquare Capital LLC increased its holdings in shares of Mettler-Toledo International by 2.0% in the 3rd quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock worth $693,000 after buying an additional 9 shares during the last quarter. Glenmede Trust Co. NA raised its position in Mettler-Toledo International by 2.2% during the third quarter. Glenmede Trust Co. NA now owns 1,155 shares of the medical instruments supplier’s stock valued at $1,732,000 after purchasing an additional 25 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Mettler-Toledo International by 4.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,989 shares of the medical instruments supplier’s stock worth $8,982,000 after purchasing an additional 234 shares in the last quarter. Public Sector Pension Investment Board increased its position in shares of Mettler-Toledo International by 12.3% during the 3rd quarter. Public Sector Pension Investment Board now owns 915 shares of the medical instruments supplier’s stock valued at $1,372,000 after purchasing an additional 100 shares during the last quarter. Finally, Edgestream Partners L.P. raised its holdings in shares of Mettler-Toledo International by 1,270.6% during the 3rd quarter. Edgestream Partners L.P. now owns 3,262 shares of the medical instruments supplier’s stock valued at $4,892,000 after buying an additional 3,024 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Christian Magloth sold 790 shares of the company’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Down 1.4 %

Shares of Mettler-Toledo International stock opened at $1,176.04 on Monday. The business has a 50 day moving average of $1,283.84 and a 200 day moving average of $1,302.91. Mettler-Toledo International Inc. has a 52 week low of $1,142.91 and a 52 week high of $1,546.93. The company has a market cap of $24.51 billion, a PE ratio of 29.02, a P/E/G ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on MTD. Robert W. Baird upped their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Citigroup lowered their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Evercore ISI raised their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. Finally, Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. One analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,380.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.